APA (7th ed.) Citation

Arvat, E., Ramunni, J., Maccagno, B., Giordano, R., Broglio, F., Deghenghi, R., . . . Ghigo, E. (1999). Corticotropin-Releasing Effect of Hexarelin, a Peptidyl GH Secretagogue, in Normal Subjects Pretreated with Metyrapone or RU-486, a Glucocorticoid Receptor Antagonist, and in Patients with Addison’s Disease. Neuroendocrinology, 70(3), 200-206. https://doi.org/10.1159/000054477

Chicago Style (17th ed.) Citation

Arvat, Emanuela, Josefina Ramunni, Barbara Maccagno, Roberta Giordano, Fabio Broglio, Romano Deghenghi, Marco Boscaro, and Ezio Ghigo. "Corticotropin-Releasing Effect of Hexarelin, a Peptidyl GH Secretagogue, in Normal Subjects Pretreated with Metyrapone or RU-486, a Glucocorticoid Receptor Antagonist, and in Patients with Addison’s Disease." Neuroendocrinology 70, no. 3 (1999): 200-206. https://doi.org/10.1159/000054477.

MLA (9th ed.) Citation

Arvat, Emanuela, et al. "Corticotropin-Releasing Effect of Hexarelin, a Peptidyl GH Secretagogue, in Normal Subjects Pretreated with Metyrapone or RU-486, a Glucocorticoid Receptor Antagonist, and in Patients with Addison’s Disease." Neuroendocrinology, vol. 70, no. 3, 1999, pp. 200-206, https://doi.org/10.1159/000054477.